EGFR and non-small cell lung carcinoma: To evaluate the prognostic value of the lipids in NSCLC, the parameters, including demographic data, clinicopathological features, smoking status, preoperative chemotherapy, postoperative chemotherapy, anti-EGFR drug treatment, EGFR mutation status and lipid profile were evaluated by the univariate and multivariate Cox regression model (Table 1).